L-clausenamide

左黄皮酰胺

Report date: 2026/01/27 10:16:48
NME

Base Information

Drug NameL-clausenamide
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsCognitive DysfunctionMemory DisordersDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical ScienceQingdao Huanghai Pharmaceutical Co LtdGuangzhou Nuohao Pharmaceutical Technology Co Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Nuohao Pharmaceutical Technology Co LtdQingdao Huanghai Pharmaceutical Co LtdInstitue Of Materia Medica Chinese Academy Of Medical Science
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionMemory DisordersDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A